Billy Amzal Selected Research

Everolimus

1/2017	Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma.
10/2015	An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Billy Amzal Research Topics

Disease

3	Renal Cell Carcinoma (Grawitz Tumor) 07/2019 - 10/2015
2	Neoplasms (Cancer) 10/2015 - 12/2011
1	Psoriatic Arthritis 09/2021
1	Infections 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 02/2017
1	Disease Progression 02/2017
1	Urinary Retention 02/2017
1	Prostatitis 02/2017
1	Erectile Dysfunction 02/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2016
1	Alzheimer Disease (Alzheimer's Disease) 12/2007
1	Parkinson Disease (Parkinson's Disease) 12/2007
1	Dementia (Dementias) 12/2007

Drug/Important Bio-Agent (IBA)

2	cabozantinibIBA 07/2019 - 01/2017
2	NivolumabIBA 07/2019 - 01/2017
2	Everolimus FDA Link 01/2017 - 10/2015
2	Axitinib (AG 013736)IBA 01/2017 - 10/2015
1	secukinumabIBA 09/2021
1	padeliporfinIBA 02/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	efalizumab (Raptiva)FDA Link 09/2016
1	Sunitinib (Sutent)FDA Link 10/2015
1	CadmiumIBA 12/2011
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2011
1	Rivastigmine (Exelon)FDA LinkGeneric 12/2007

Therapy/Procedure

2	Therapeutics 01/2017 - 10/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2020
1	Lasers (Laser) 02/2017
1	Photochemotherapy (Photodynamic Therapy) 02/2017
1	Transdermal Patch 12/2007